Sarepta tips Roche pact to spur manufacturing capacity expansion
Sarepta expects its $1bn gene therapy pact with Roche to necessitate the addition of manufacturing capacity.
Sarepta expects its $1bn gene therapy pact with Roche to necessitate the addition of manufacturing capacity.